Butterfly Network (BFLY) Change in Accured Expenses (2020 - 2026)
Butterfly Network (BFLY) reported Change in Accured Expenses of $1.6 million for Q1 2026, up 131.36% on a YoY basis from $688542.5 in Q1 2025, and down 58.13% sequentially from $3.8 million in Q4 2025.
Butterfly Network (BFLY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Change in Accured Expenses data on file, last reported at $1.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 131.36% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 475.78% YoY), and the FY2025 full-year result was $5.1 million, up 33.61% from the prior year.
- Change in Accured Expenses eased to $1.6 million in Q1 2026, from $3.8 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $4.8 million in Q3 2025 to a low of -$5.1 million in Q1 2025.
- A 5-year average of $459882.4 and a median of $329000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses tumbled 389.36% in 2023 and surged 4931.17% in 2024, its largest moves.
- Tracing BFLY's Change in Accured Expenses over 5 years: stood at $1.1 million in 2022, then sank by 106.75% to -$77000.0 in 2023, then surged by 4931.17% to $3.7 million in 2024, then gained by 2.28% to $3.8 million in 2025, then sank by 58.13% to $1.6 million in 2026.
- Business Quant data shows BFLY's Change in Accured Expenses at $1.6 million in Q1 2026, $3.8 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 1.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.59 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | -5.08 Mn |
| Mar 31, 2025 | -5.08 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Dec 31, 2024 | 3.72 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Sep 30, 2024 | 3.16 Mn |
| Jun 30, 2024 | 246,000.00 |
| Jun 30, 2024 | 246,000.00 |
| Mar 31, 2024 | -3.31 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Dec 31, 2023 | -77,000.00 |
| Dec 31, 2023 | -77,000.00 |